Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

Robert J Brogan; Despina Eleftheriou; James Gnanapragasam; Nigel J Klein; Paul A Brogan

doi:10.1186/1546-0096-7-3

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report

Pediatr Rheumatol Online J. 2009 Jan 21:7:3. doi: 10.1186/1546-0096-7-3.

Authors

Robert J Brogan¹, Despina Eleftheriou, James Gnanapragasam, Nigel J Klein, Paul A Brogan

Affiliation

¹ Department of Paediatric Rheumatology, UCL Institute of Child Health and Great Ormond Street Hospital, 30 Guilford Street, London, UK. robbie.brogan@googlemail.com.

Abstract

This case report describes an 8 year old boy with IVIG resistant Kawasaki disease complicated by severe bilateral coronary artery aneurysms successfully treated with infliximab, a monoclonal antibody against tumour necrosis factor alpha.